Skip to main content

Scott B. Luftglass

  • Vice Chairman | Litigation Partner

New York

T: +1.212.859.8968

Headshot of Scott B. Luftglass

Scott B. Luftglass is the vice chairman of Fried Frank and is a member of the firm’s Governance Committee. He is a litigation partner and the co-head of the Securities and Shareholder Litigation Practice. His practice focuses on representing corporations, boards of directors, special committees, senior management and financial sponsors in connection with corporate governance matters, crisis management, significant corporate transactions, securities litigation, shareholder and derivative litigation and activism defense. Scott also represents clients, particularly special committees, in internal investigations and responses to shareholder demands.

Throughout his career, Scott has represented clients in more than 250 public company mergers and acquisitions transactions (and related litigation) and securities litigation across a wide range of industries. He has represented the boards of directors, special committees, or senior management of large public companies, including Aerie Pharmaceuticals, Aetna, AstraZeneca, Bob Evans, Clover Health, Coach, Comcast, Conagra, CVS Health, ExxonMobil, H.J. Heinz Company, PepsiCo, Roche, Seritage Growth Properties, Shire, Sinclair Broadcast Group, SS&C Technologies, TE Connectivity, Tyson Foods and Warner Chilcott, as well as significant financial sponsors, including AEA Investors, Apollo Global Management, Conversant Capital, CVC, Permira and Third Point. 

Scott also regularly counsels global investment banks in transactions and litigation, including JPMorgan, Centerview, Evercore, Greenhill, Lazard and Morgan Stanley.

Scott is a frequent speaker at conferences and panels focused on corporate governance, mergers and acquisitions, and the federal securities laws. He has been a regular panelist at the Tulane University Law School Annual Corporate Law Institute, Harvard Law School’s Corporate Governance Roundtable and PLI’s Delaware Law Developments Seminar. He has also been a guest lecturer on mergers and acquisitions and litigation at Yale Law School and the University of Pennsylvania Law School.

Scott is one of the lead authors of Takeover Defense: Mergers and Acquisitions (Wolters Kluwer 9th edition), a treatise widely recognized as a definitive legal resource in this area and repeatedly cited by the Delaware Court of Chancery. He also co-authors the chapter entitled “Mergers and Acquisitions” in Business and Commercial Litigation in Federal Courts, Fourth Edition, a treatise released by Thomson Reuters and updated annually. In addition, he frequently authors articles concerning significant developments in the Delaware courts, mergers and acquisitions litigation, and corporate governance.

Scott is recognized by Chambers USA in the category of Securities Litigation: New York, where sources note that “he has an endless knowledge of black letter law but he combines that with extraordinarily good judgment and tactical strategic advice,” and “he’s a litigator but he also really understands the corporate side of an issue.” He is recognized by The Legal 500 as a Leading Lawyer in the categories of Securities Litigation and M&A Litigation, where a source notes that he is an “exceptional partner to our company — proactive, industrious, experienced and always available,” and by Benchmark Litigation as a “Litigation Star” in securities and commercial litigation, where a source notes his “excellent judgment and communication skills.” He is also recognized by Lawdragon as one of the 500 Leading Litigators in America.

Scott is a Fellow of the American College of Governance Counsel and serves on the Board of Advisors for the NYU Law Institute for Corporate Governance & Finance and on the Board of Advisors for the Penn Law Institute for Law & Economics. He is also a member of the Dean’s Council at the University of Virginia School of Law.

Representative Work Highlights:

Companies and Boards in Connection with Securities Class Actions, Derivative Litigation, and Shareholder Demands

  • Apollo Global Management in connection with litigation challenging payments made to Apollo’s Co-Founders relating to the modification of a tax receivables agreement
  • Special Committee of Pegasystems, Inc. in connection with an investigation into allegations raised following an adverse $2 billion jury verdict relating to alleged misappropriation of trade secrets
  • Sinclair Broadcast Group in connection with federal securities litigation, derivative litigation, and government investigations relating to its terminated merger with Tribune Media Company
  • Evoqua Water Technologies in connection federal securities litigation, derivative litigation, and government investigations relating to alleged revenue recognition issues at a subsidiary
  • Seritage Growth Properties in connection with fraudulent conveyance litigation arising out of the Sears bankruptcy proceedings
  • Seritage Growth Properties in connection with derivative litigation challenging the transactions with Sears Holdings that resulted in the creation of Seritage Growth Properties as a separate, publicly traded company
  • Special Committee of IAC in connection with litigation challenging proposed restructuring of IAC’s capital structure, including the proposed creation of a third class of stock
  • Special Committee of Clover Health in connection with an investigation into allegations raised in a short-seller’s report

Companies and Boards in Connection with Litigation Challenging Public Company M&A Transactions:

  • Apollo Global Management in various lawsuits relating to over 15 public company M&A transactions
  • CVS Health in its acquisition of Signify Health
  • Permira in its acquisitions of McAfee, ZenDesk, and Mimecast
  • Aerie Pharmaceuticals in its sale to Alcon
  • NorthStar Asset Management in merger of Colony Capital, NorthStar Asset Management Group and NorthStar Realty Finance
  • CVC Capital in transaction involving Actua, Velocity and Bolt
  • Special Committee of Apollo Commercial Real Estate Finance in merger with Apollo Residential Mortgage, Inc.
  • Four directors of Xerox in various lawsuits relating to the now-terminated merger of Fuji and Xerox
  • The Board of Directors of Bob Evans Restaurants in the sale of Bob Evans to Post Holdings
  • H.J. Heinz Company in its sale to Berkshire Hathaway Inc. and 3G Capital, Inc.
  • Roche Holding AG in its acquisitions of InterMune Inc., Genentech Inc., Ventana Medical Systems, Inc., and Anadys Pharmaceuticals Inc.
  • Shire plc in its acquisitions of NPS Pharmaceuticals Inc. and ViroPharma Inc.
  • Bio-Reference Laboratories, Inc. in its sale to Opko Health, Inc.
  • Comcast Corp. in its proposed acquisition of Time Warner Cable, Inc.
  • Aetna, Inc. in its acquisition of Humana Inc.
  • AstraZeneca plc in its acquisitions of Amylin Pharmaceuticals, Inc. and Omthera Pharmaceuticals, Inc.
  • Tyson Foods, Inc. in its acquisition of The Hillshire Brands Company
  • SS&C Technologies Holdings, Inc. in its acquisition of Advent Software, Inc.
  • Warner Chilcott plc in its sale to Actavis plc
  • Thomas & Betts Corp. in its sale to ABB Ltd.
  • Smith & Nephew plc in its acquisition of ArthoCare Corp.
  • ConAgra Foods, Inc. in its acquisition of Ralcorp Holdings, Inc.
  • TE Connectivity Ltd. in its acquisitions of Measurement Specialties, Inc. and ADC Telecommunications, Inc.
  • Exxon Mobil Corp. in its acquisition of XTO Energy Inc .
  • PepsiCo Inc. in its acquisitions of The PepsiCo Bottling Group, Inc. and PepsiAmericas Inc.

Professional associations

  • Fellow, American College of Governance Counsel
  • Member, Board of Advisors, NYU School of Law Institute of Corporate Governance and Finance
  • Member, Board of Advisors, University of Pennsylvania Law School, Institute for Law and Economics
  • Member, Advisory Council, Law Firm Antiracism Alliance

News and insight

M&A/PE Quarterly |

M&A/PE Quarterly - Q3 2026⟶

Events

Back to top ↑